SpringerPlus

Table 1 Baseline characteristics of study

From: Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis

Factor	Group	Overall
		N = 125
Age,y		75 [66, 82]
Sex	M/F	85(68.0)/40 (32.0)
Cirrhosis	No/Yes	112 (89.6)/13(10.4)
Sepsis	Pulmonary	78 (62.4)
	Nonpulmonary	47 (37.6)
APACHE.II		23 [18, 27]
McCabe	1/2/3	114 (91.2)/5(4.0)/6(4.8)
ARDS severity	Mild	10 (8.0)
	Moderate	58 (46.4)
	Severe	57 (45.6)
SOFA		7 [5, 11]
PaO₂/FiO₂, mmHg		106.80 [75.1, 139.7]
CT.score		213.3 [184.8, 268.5]
Albumin, g/dL		2.8 [2.40, 3.20]
WBC		9600 [4200, 14,400]
C-reactive protein, mg/dL		15.94 [9.01, 25.70]
Lactate dehydrogenase, IU/L		308 [246, 434]
DIC score		3 [2, 4]
FDP, mg/L		11.10 [1.50, 170.70]
Antithrombin III %		66.00 [52.00, 80.00]
Platelet, X10⁴		17.90 [10.10, 26.40]
D.dimer.μg/ml.		5.60 [2.70, 11.00]
AZM use (%)		29(23.2)
Death (%)		58 (46.4)

n (%), median [IQR]
APACHE acute physiology and chronic health evaluation, ARDS acute respiratory distress syndrome, AZM azithromycin, DIC disseminated intravascular coagulation, FDP fibrin/fibrinogen degradation products, SOFA Sequential Organ Failure Assessment score, WBC white blood cell count

Back to article page